| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.32 | 9e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |